As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Thermo Fisher Scientific: Arrowpoint Investment Partners Singapore Pte. Ltd., Wolverine Trading LLC, Squarepoint Ops LLC, Point72 Asset Management L.P., Man Group plc, Maven Securities LTD, Millennium Management LLC, LMR Partners LLP, Jefferies Financial Group Inc., Group One Trading LLC, Focus Partners Wealth, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cresset Asset Management LLC, Cubist Systematic Strategies LLC, Citadel Advisors LLC, Capstone Investment Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Lido Advisors LLC, Tudor Investment Corp ET AL, Boothbay Fund Management LLC, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, Hsbc Holdings PLC, HAP Trading LLC, Brant Point Investment Management LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Harbert Fund Advisors Inc., Capula Management Ltd, Oribel Capital Management LP, Wells Fargo & Company MN, One River Asset Management LLC, JPMorgan Chase & Co., LPL Financial LLC, Simplex Trading LLC, Garda Capital Partners LP, Allianz Asset Management GmbH, Wolverine Asset Management LLC, IMC Chicago LLC, Baader Bank Aktiengesellschaft, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.